Webinars

Search

Saved Activities

 x 

0 Activities
0 Activities
No image set

Management of Rare RCC Histologies

Array

Activity Info

This lecture identifies targetable pathways that drive specific RCC histologies and distinguish which renal cell carcinoma histologies can respond to tyrosine kinase inhibitors, immune checkpoint blockade, or cytotoxic chemotherapy.
Email

CME Information is available with the activity.

Tags

Webinar | CME (AMA PRA Category 1 Credit) | 1.0 - 60 mins | Internal Medicine | Family Medicine | Diabetes | Endocrinology |